Patent Assignment
Reel/Frame 054392/0656
Change of Name
Recorded: 2020-11-12
Pages: 4
Assignor
SEATTLE GENETICS, INC.
Executed: 2020-10-06
Assignee
SEAGEN INC.
21823 30TH DRIVE SE, BOTHELL, WASHINGTON, 98021
Covered Properties
(28)
Recombinant Anti-CD40 Antibody and Uses Thereof
Patent:
6,946,129 →
Application:
09/328,296 →
Recombinant Anti-CD30 Antibodies and Uses Thereof
Patent:
7,090,843 →
Application:
09/724,406 →
Nucleic Acids Encoding Anti-CD40 Proteins and Methods of Producing Recombinant Anti-CD40 Proteins
Patent:
6,838,261 →
Application:
09/724,409 →
Methods for the Treatment and Prevention of Cancer Using Anti-CD40 Antibodies
Patent:
6,843,989 →
Application:
09/724,530 →
Drug Conjugates and Their Use for Treating Cancer, an Autoimmune Disease or an Infectious Disease
Methods for the Treatment of Cancer Using Anti-CD40 Antibodies
Methods of Treating Neoplastic, Autoimmune and Inflammatory Diseases
CD19 Binding Agents and Uses Thereof
Methods for the Treatment of Cancer Using Anti-CD40 Antibodies
Drug Conjugates and Their Use for Treating Cancer, an Autoimmune Disease or an Infectious Disease
CD30 Binding Agents and Uses Thereof
Drug Conjugates and Their Use for Treating Cancer, an Autoimmune Disease or an Infectious Disease
Methods for Augmenting an Immune Response Using Anti-CD40 Antibodies
Combination Therapy with Antibody-Drug Conjugates
Drug Conjugates and Their Use for Treating Cancer, an Autoimmune Disease or an Infectious Disease
Post-Relapse Treatment of CD30 Expressing Lymphomas
Patent:
8,758,758 →
Application:
12/985,687 →
CD19 Binding Agents and Uses Thereof
Weekly Dosing Regimens for Anti-CD30 Vc-Pab-Mmae Antibody Drug-Conjugates
CD19 Binding Agents and Uses Thereof
Combination Therapy with Antibody-Drug Conjugates
Detection and Treatment of CD30+ Cancers
CD33 Antibodies and Use of Same to Treat Cancer
CD19 Binding Agents and Uses Thereof
Weekly Dosing Regimens for Anti-CD30 Vc-Pab-Mmae Antibody Drug-Conjugates
CD33 Antibodies and Use of Same to Treat Cancer
Weekly Dosing Regimens for Anti-CD30 Vc-Pab-Mmae Antibody Drug-Conjugates
Weekly Dosing Regimens for Anti-CD30 Vc-Pab-Mmae Antibody Drug-Conjugates
Weekly Dosing Regimens for Anti-CD30 Vc-Pab-Mmae Antibody Drug-Conjugates
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 8, 1999
From: SIEGALL, CLAY B.; WAHL, ALAN F.; FRANCISCO, JOSEPH A.; FELL, HENRY PERRY, JR.
To: SEATTLE GENETICS, INC.
Reel/Frame 010035/0860 →
Assignment of Assignor's Interest
Jan 26, 2001
From: FRANCISCO, JOSEPH A.; RISDON, GRANT; WAHL, ALAN F.; SIEGALL, CLAY
To: SEATTLE GENETICS, INC.
Reel/Frame 011508/0339 →
Assignment of Assignor's Interest
Jul 8, 2005
From: SENTER, PETER D.; DORONINA, SVETLANA O.; TOKI, BRIAN E.
To: SEATTLE GENETICS, INC.
Reel/Frame 016758/0802 →
Assignment of Assignor's Interest
Jun 3, 2008
From: DRACHMAN, JONATHAN G.; RISDON, GRANT; OFLAZOGLU, EZOGELIN; SUTHERLAND, MAY KUNG
To: SEATTLE GENETICS, INC.
Reel/Frame 021043/0967 →
Assignment of Assignor's Interest
Jan 19, 2009
From: MCDONAGH, CHARLOTTE; CERVENY, CHARLES G.; BENJAMIN, DENNIS; CARTER, PAUL
To: SEATTLE GENETICS, INC.
Reel/Frame 022124/0825 →
Assignment of Assignor's Interest
Apr 29, 2010
From: GRUYTERS, EZOGELIN; SIEVERS, ERIC; GERBER, HANS-PETER
To: SEATTLE GENETICS, INC.
Reel/Frame 024313/0401 →
Assignment of Assignor's Interest
Jan 14, 2011
From: SIEVERS, ERIC; KENNEDY, DANA
To: SEATTLE GENETICS, INC.
Reel/Frame 025640/0983 →
Assignment of Assignor's Interest
Sep 14, 2011
From: OLBERG, DAG ERLAND; ARUKWE, JOSEPH MADUABUCHI
To: GE HEALTHCARE LIMITED
Reel/Frame 026907/0337 →